APREPITANT
Generic: APREPITANT
Golden State Medical SupplyManufacturer
ORALRoute
APREPITANTActive Substance
2020-10-21Original Approval
APREPITANT is FDA application ANDA211835, sponsored by TORRENT. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-04-13
Aprepitant Capsule, USP, 40 mg, 1 capsule per unit dose package, Rx only, MFG: Sandoz Pharma, NDC 0781-2321-06cGMP deviations: Temperature abuse
Class III2018-11-27
Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark PharmaceuticaShortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in
Top Reported Reactions
1
FATIGUE
1,287 reports
2
NAUSEA
1,105 reports
3
PYREXIA
921 reports
4
OFF LABEL USE
872 reports
5
ALOPECIA
823 reports
6
DYSPNOEA
806 reports
7
DIARRHOEA
770 reports
8
RASH
764 reports
9
VOMITING
702 reports
10
HYPERSENSITIVITY
701 reports